Signal Transduction and Targeted Therapy: PAK1 is a broad-spectrum anti-SARS-CoV-2 target
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has had a significant impact on healthcare systems and economies worldwide. The emergence of new viral strains represents a major challenge in the development of effective antiviral agents. The spike protein of SARS-CoV-2 interacts with...